16:30
#35 Are pudendal afferent fibres involved in autonomic dysreflexia?
Reitz A. 1, Schmid D. M. 2, Curt A. 3, Knapp P. A. 3, Schurch B. 3 1. Neurourological unit, ParaCare, Balgrist University Hospital, 2. Department of Urology, University Hospital Zurich, 3. ParaCare, Balgrist University Hospital Zurich
16:37
#36 LOWER URINARY TRACT DYSFUNCTION IN AMBULATORY NEUROPATHIC PATIENTS WITH INCOMPLETE SPINAL CORD INJURY
Hamid R. 1, Zafirakis H. 2, Arya M. 3, Shah P. 4 1. Spinal Injuries Unit, Royal Notaional Orthopaedic Hospital, Stanmore, 2. Royal National Orhtopaedic Hospital, Stanmore, 3. Institute of Urology and Nephrology, London, 4. Royal National Orhtopaedic Hospital, Stanmore &Ins
16:45
#37 URINARY INCONTINENCE FOLLOWING RADICAL SURGERY IN RECTAL CANCER
Miyai K. 1, Asakura T. 1, Takahashi T. 1 1. Yokohama City Kouwan Hospital
16:52
#38 EARLY RESULTS OF INTRAURETHRAL MACROPLASTIQUE FOR POST RADICAL PROSTATECTOMY STRESS INCONTINENCE
Herschorn S. 1, Buencamino D. 2 1. University of Toronto, 2. Sunnybrook Hospital
17:00
#39 The Treatment of Detrusor Hyperreflexia Using Botulinum A Toxin in Myelomeningocele Patients Unresponsive to Anticholinergic Therapy
Corcos J. 1, Al-Taweel W. 1, Pippi Salle J. 1, Capolicchio G. 1, Jednak R. 1 1. McGill University
17:07
#40 THE NEUROMETER AS AN INSTRUMENT FOR APPROPRIATE SELECTION AND MONITORING OF INTRAVESICAL RESINIFERATOXIN THERAPY FOR PATIENTS WITH DETRUSOR HYPERREFLEXIA
Ukimura O. 1, Inaba M. 1, Iwata T. 1, Ushijima S. 1, Honjo H. 1, Miki T. 1 1. Kyoto Prefectural University of Medicine
17:15
#41 Efficacy and tolerance of intravesical instillation of capsaicin and resiniferatoxin for treatment of detrusor hyperreflexia in spinal cord injured patients. A double blind controlled study:preliminary results
de Sèze M. 1, Wiart L. 2, de Sèze M. 3, Dosque J. 4, Hazane C. 4, Saubion J. 4, Moore N. 5, Barat M. 3, Joseph P. 3 1. Neurologic rehabilitation unit. University Hospital Pellegrin., 2. Rehabilitation center Tour de Gassies 33523 Bruges, 3. Rehabilitation unit. University hospital Pellegrin, 4. Pharmacology departmentUniversity hospital Pellegr, 5. Toxicology departmentUniversity hospital Pellegrin
17:22
#42 THE USE OF GABAPENTINE IN THE TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY: PRELIMINARY URODYNAMIC AND CLINICAL RESULTS.
Antonio Carbone G. P. 1, Parascani R. 2, Morello P. 2, Tubaro A. 2, Di Crosta G. 2 1. La Sapienza University, 2. “La Sapienza” University of Rome, Ital